C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2011
12/15/2011	US20110306054 Methods for molecular detection
12/15/2011	US20110306053 Amplification System with Spatial Separation
12/15/2011	US20110306052 Form-Locking Gripping System
12/15/2011	US20110306051 Method for separating and detecting an analyte
12/15/2011	US20110306050 Method and apparatus for detecting specific dna sequences
12/15/2011	US20110306049 Method for detecting gynecologic cancer
12/15/2011	US20110306048 Bovine polymorphisms and methods of predicting bovine traits
12/15/2011	US20110306047 Compositions and Methods for RNA Hybridization Applications
12/15/2011	US20110306046 Probes and Primers for Detection of Malaria
12/15/2011	US20110306045 Method for Confirming a Diagnosis of Rolandic Epilepsy
12/15/2011	US20110306044 Delta3, fthma-070, tango85, tango77, spoil, neokine, tango129, and integrin alpha subunit protein and nucleic acid molecules and uses thereof
12/15/2011	US20110306043 Devices and methods for enrichment and alteration of circulating tumor cells and other particles
12/15/2011	US20110306042 Determination of chromatin conformation
12/15/2011	US20110306041 Device for cell culture
12/15/2011	US20110306040 Cpg receptor (cpg-r) and methods relating thereto
12/15/2011	US20110306039 Apparatus for single-molecule detection
12/15/2011	US20110306038 Assay for detection of human parvovirus nucleic acid
12/15/2011	US20110306037 Oligonucleotuide probes and primers for detection of hepatitis b virus
12/15/2011	US20110306036 RT-LAMP assay for the detection of pan-serotype dengue virus
12/15/2011	US20110306035 Methods and Compositions for Detection of a Pathogen, Disease, Medical Condition, or Biomarker Thereof
12/15/2011	US20110306034 Method for isolating cells and disease vectors from bodily fluids
12/15/2011	US20110305725 Methods and compositions for immunizing pigs against porcine circovirus
12/15/2011	US20110305721 Compounds and methods for immunotherapy and diagnosis of tuberculosis
12/15/2011	US20110305717 Cultured myeloid dendritic cells isolated from peyer's patches and uses thereof
12/15/2011	US20110305709 Calcium sensor stim1 and the platelet soc channel orai1 (cracm1) are essential for pathological thrombus formation
12/15/2011	US20110305705 Antibodies to thymic stromal lymphopoietin receptor molecules and uses thereof
12/15/2011	US20110305689 Treatment of chronic inflammatory respiratory disorders
12/15/2011	US20110305677 Human embryonic stem cell cultures, and compositions and methods for growing same
12/15/2011	US20110305673 Compositions and methods for tissue repair
12/15/2011	US20110305641 Compositions And Methods For Treatment Of Angiogenesis-Associated Ocular Disorders
12/15/2011	US20110305640 Method to treat psoriasis and other hyperproliferative skin disorders
12/15/2011	US20110305638 Modulation of Macrophage Activation
12/15/2011	US20110305636 Compounds, compositions, methods of synthesis, and methods of treatment
12/15/2011	US20110305634 Methods and systems for adenovirus interaction with desmoglein 2 (DSG2)
12/15/2011	US20110305633 Methods for Treatment, the Prognostic Assessment and the Detection of Breast Cancer
12/15/2011	US20110303538 Redox Polymers
12/15/2011	US20110303537 Redox Polymers
12/15/2011	DE102010009339A1 Detecting toxins and pyrogens, comprises carrying out immune reaction of Tetrahymena on the substance to be tested, incubating and detecting the immune response by chemical color reaction for the detection the nitrogen monoxide
12/15/2011	DE102010003781A1 Verfahren zum Nachweis spezifischer Nukleinsäuresequenzen A method for detection of specific nucleic acid sequences
12/15/2011	DE102010001332A1 Producing medicament comprises imaging amplified genome segments in isolated tumor sample, reproducing and sequencing fusion area of fused amplified genome segments in amplicons and providing sample, which specifically bind to fusion area
12/15/2011	DE102008005062B4 Vorrichtung und Verfahren zum Bestimmen einer pharmazeutischen Aktivität eines Moleküls Apparatus and method for determining a pharmaceutical activity of a molecule
12/15/2011	CA2802059A1 Nucleic acid detection and quantification by post-hybridization labeling and universal encoding
12/15/2011	CA2802049A1 Scanning multifunctional particles
12/15/2011	CA2801894A1 Filtration methods and devices
12/15/2011	CA2801849A1 Methods and kits for diagnosing conditions related to hypoxia
12/15/2011	CA2801564A1 Compositions and methods for protein production
12/15/2011	CA2801501A1 Pathways characterization of cells
12/15/2011	CA2801107A1 Gene expression markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
12/15/2011	CA2801039A1 Enumeration of nucleic acids
12/15/2011	CA2791627A1 Mass spectrometric measurement of .beta.-lactamase resistances
12/15/2011	CA2778283A1 Apparatus for single-molecule detection
12/14/2011	EP2395358A2 Covalent tethering of functional groups to proteins and substrates therefor
12/14/2011	EP2395348A1 Electrochemical sensor and method for manufacturing same
12/14/2011	EP2395114A1 Diagnosis kit and chip for bladder cancer using bladder cancer specific methylation marker gene
12/14/2011	EP2395113A1 Methods and compositions for isolating nucleic acid sequence variants
12/14/2011	EP2395112A1 Methods for predicting and overcoming resistance to chemotherapy in ovarian cancer and for predicting colon cancer occurrence
12/14/2011	EP2395111A1 Methods for prenatal diagnosis of chromosomal abnormalities
12/14/2011	EP2395110A1 Method for measuring resistance or sensitivity to docetaxel
12/14/2011	EP2395109A1 Method for measuring resistance or sensitivity to docetaxel
12/14/2011	EP2395108A1 Method for measuring resistance or sensitivity to docetaxel
12/14/2011	EP2395107A1 Method for measuring resistance or sensitivity to docetaxel
12/14/2011	EP2395106A1 Method for measuring resistance or sensitivity to docetaxel
12/14/2011	EP2395105A1 Method for measuring resistance or sensitivity to docetaxel
12/14/2011	EP2395104A1 Method for measuring resistance or sensitivity to docetaxel
12/14/2011	EP2395103A1 Method for measuring resistance or sensitivity to docetaxel
12/14/2011	EP2395102A1 Method for measuring resistance or sensitivity to docetaxel
12/14/2011	EP2395101A1 DNA methylation markers associated with the CpG island methylator phenotype (cimp) in human colorectal cancer
12/14/2011	EP2395100A2 Novel diagnostic marker for type 1 diabetes mellitus
12/14/2011	EP2395098A1 Base specific cleavage of methylation-specific amplification products in combination with mass analysis
12/14/2011	EP2395086A1 Inhibitors of micro-RNAs for use for preventing and/or attenuating skin ageing and/or for hydrating skin
12/14/2011	EP2395082A1 Extraction of nucleic acids from wax-embedded samples
12/14/2011	EP2395078A2 Covalent tethering of functional groups to proteins and substrates therefor
12/14/2011	EP2395055A1 Fluorescent solvatochromic pigment
12/14/2011	EP2395012A2 Modified siRNA molecules and uses thereof
12/14/2011	EP2394655A2 Epitope sequences
12/14/2011	EP2394170A2 Methods of detecting colorectal cancer
12/14/2011	EP2394166A1 Methods and compositions for diagnosis and prognosis of renal injury and failure
12/14/2011	EP2394159A2 Methods for screening candidate agents for modulating prorenin and renin, assays for detecting prorenin, and antibodies used therein
12/14/2011	EP2393946A1 Determination of the liver toxicity of an agent
12/14/2011	EP2393945A1 Dual targeting of mir-208 and mir-499 in the treatment of cardiac disorders
12/14/2011	EP2393943A2 Improvements in and relating to performance
12/14/2011	EP2393942A2 Improvements in and relating to microfluidic devices for processing a sample
12/14/2011	EP2393941A2 Improvements in and relating to microfluidic devices for processing a sample
12/14/2011	EP2393940A1 Generation of random double strand breaks in dna using enzymes
12/14/2011	EP2393939A1 A snp marker of breast and ovarian cancer risk
12/14/2011	EP2393938A1 Cell based assays for the triglyceride synthesis pathway
12/14/2011	EP2393937A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure
12/14/2011	EP2393936A2 Compositions, kits, and methods for determining plasmin activity
12/14/2011	EP2393935A1 Rapid detection of bacteria using mass spectrometric analysis
12/14/2011	EP2393586A1 Thermal validation apparatus, assembly including a device for the thermal processing of biological samples and such an apparatus, and method for manufacturing such an apparatus
12/14/2011	EP2393349A1 Xanthomonas campestris pv. campestris resistant brassica plant and preparation thereof
12/14/2011	EP2276859B1 Detection of pcr products in gel electrophoresis
12/14/2011	EP2038430B1 Toll like receptor 4 dysfunction and the biological applications thereof
12/14/2011	EP1943272B1 Novel cxc-chemokine antagonists
12/14/2011	EP1926997B1 Mass labels
12/14/2011	EP1680959B1 Mouse model wherein responsiveness to lipopolysaccharide (lps) is specifically impaired
12/14/2011	EP1641492B1 Controlled platelet activation to monitor therapy of adp antagonists
12/14/2011	EP1552308B1 Demethylated and/or oxidized membrane dna and use thereof in the diagnostic of autoimmune diseases
12/14/2011	EP1166121B1 Selection of intracellular immunoglobulins
12/14/2011	EP1085090B1 IgA NEPHROPATHY-ASSOCIATED DNA

1 ... 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 ... 3003